Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bruker Corp (BRKR)

Bruker Corp (BRKR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,398,875
  • Shares Outstanding, K 151,565
  • Annual Sales, $ 1,988 M
  • Annual Income, $ 157,800 K
  • 60-Month Beta 1.29
  • Price/Sales 5.14
  • Price/Cash Flow 35.78
  • Price/Book 10.60
Trade BRKR with:

Options Overview

Details
  • Implied Volatility 31.56%
  • Historical Volatility 25.59%
  • IV Percentile 1%
  • IV Rank 16.78%
  • IV High 73.12% on 04/16/20
  • IV Low 23.18% on 02/19/21
  • Put/Call Vol Ratio 0.05
  • Today's Volume 96
  • Volume Avg (30-Day) 136
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,579
  • Open Int (30-Day) 688

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.32
  • Number of Estimates 5
  • High Estimate 0.34
  • Low Estimate 0.31
  • Prior Year 0.14
  • Growth Rate Est. (year over year) +128.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.83 +14.67%
on 03/18/21
69.30 -1.00%
on 04/06/21
+7.76 (+12.75%)
since 03/09/21
3-Month
54.46 +25.98%
on 02/03/21
69.92 -1.87%
on 02/12/21
+9.63 (+16.33%)
since 01/08/21
52-Week
34.79 +97.21%
on 04/21/20
69.92 -1.87%
on 02/12/21
+31.81 (+86.44%)
since 04/09/20

Most Recent Stories

More News
Here's Why You Should Hold on to Bruker (BRKR) Stock for Now

Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.

XRAY : 64.20 (+0.08%)
HOLX : 73.63 (+0.07%)
HRC : 112.94 (+1.40%)
BRKR : 68.61 (+1.72%)
Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging Research

At the Experimental Nuclear Magnetic Resonance Conference 2021 (ENC), Bruker Corporation (Nasdaq: BRKR) announces that the Forschungszentrum Juelich (FZJ), Germany has expanded its research into functional...

NUMG : 52.65 (+0.75%)
BRKR : 68.61 (+1.72%)
Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs

Just prior to the 2021 Experimental Nuclear Magnetic Resonance Conference (www.enc-conference.org), Bruker Corporation (Nasdaq: BRKR) is making chemical analysis by magnetic resonance spectroscopy more...

NUMG : 52.65 (+0.75%)
BRKR : 68.61 (+1.72%)
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center

Bruker Corporation (Nasdaq: BRKR), a leading supplier of single-plane illumination microscopy (SPIM) technology for research on live cells and cleared biological samples, today announced that two Luxendo...

BRKR : 68.61 (+1.72%)
Bruker (BRKR) Down 0.2% Since Last Earnings Report: Can It Rebound?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BRKR : 68.61 (+1.72%)
Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics

Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D genomics...

BRKR : 68.61 (+1.72%)
Why Bruker Corp (BRKR) Stock Might be a Great Pick

Bruker Corp (BRKR) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.

BRKR : 68.61 (+1.72%)
GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-Based Assays for Liver Fibrosis, Cirrhosis and Liver Cancer (HCC)

CHARLESTON, S.C., /PRNewswire/ -- GlycoPath Inc., the developer of advanced bioanalytical assays based on its proprietary GlycoTyper immunoaffinity technology, announced the closing of its seed investment...

BRKR : 68.61 (+1.72%)
Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021

At the virtual 17th US HUPO Conference (US HUPO 2021), Bruker Corporation (Nasdaq: BRKR) today announces progress with several collaborations in deep, unbiased plasma proteomics, leveraging the speed,...

BRKR : 68.61 (+1.72%)
New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics

Bruker Corporation (Nasdaq: BRKR) today announces a seminal publication from the groups of Professors Matthias Mann and Fabian Theis in the journal Nature Communications with the title 'Deep learning the...

BRKR : 68.61 (+1.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

As of February 26, 2008, the renamed BRUKER CORPORATION has become the parent company of the entire Bruker group of companies. After the closing of the acquisition of the Bruker BioSpin Group, Bruker Corporation now operates in two segments, the life science and analytical (LSA) systems segment, and...

See More

Key Turning Points

3rd Resistance Point 72.33
2nd Resistance Point 70.56
1st Resistance Point 69.59
Last Price 68.61
1st Support Level 66.85
2nd Support Level 65.08
3rd Support Level 64.11

See More

52-Week High 69.92
Last Price 68.61
Fibonacci 61.8% 56.50
Fibonacci 50% 52.35
Fibonacci 38.2% 48.21
52-Week Low 34.79

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar